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EDITORIAL 
Synthetic Biology for Human Health: Issues for Ethical 
Discussion and Policy-making 
Nikola Biller-Andorno, Ruud ter Meulen, Ainsley Newson (2013) 
Synthetic biology, the application of engineering principles to (re)design and construct novel 
biological systems and devices, provides an emerging focus for ethical and policy debates on 
emerging biotechnologies. Happily, no scandal or accident has occurred to give rise to this 
ethical attention. Rather, it was the researchers themselves who invited the involvement of 
ethicists, explaining their work and asking for ethical commentary. This proactive stance was 
fuelled by the intention to avoid another backlash like the one that occurred against some 
gene technologies. Many consumers have been and are still highly sceptical about 
genetically modified food, with field trials (for example) regularly being met with public 
protest. By engaging with the ethical implications of their work early on, many researchers 
in synthetic biology hoped to prevent such reactions. So far, it looks as if they have been 
successful, as public attitudes towards synthetic biology are largely positive1. 
Despite significant early interest, the ethics of synthetic biology is still a young field. A recent 
search in PubMed, one of the major biomedical databanks containing much of the bioethical 
literature has yielded less than 100 entries for the search: “synthetic biology” AND (ethics or 
ethical). Some may claim that a reason for this relative lack of literature may be that 
synthetic biology does not give rise to any substantive ethical issues. However it is our hope 
that the papers in this special issue will convince you otherwise. 
To date, reactions to synthetic biology in the literature as well as in the wider community 
have ranged from: What's the matter? We wash bacteria down the sink all the time! to: This 
is playing God on a grand scale! A number of reports – notably the 2009 Report Ethics of 
Synthetic Biology from the European Group on Ethics in Science and New Technologies2 and 
the 2010 report from the US Presidential Commission for the Study of Bioethical Issues, New 
Directions: The Ethics of Synthetic Biology and Emerging Technologies3 – have recognized 
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both the ethical dimension and potential of synthetic biology, but have identified no 
grounds for a moratorium or other ban on this new research area. The relevance of safety 
and security issues has been recognized, however, as have potential implications for social 
justice and biodiversity. 
This special issue of Bioethics focuses on the ethical issues arising from the potential 
application of synthetic biology to human health. Synthetic biology offers promise for 
developments to benefit health, such as innovative drugs, new vaccines, tissue 
regeneration, or even entirely synthetic cells. 
Even if such applications are still rather hypothetical, they are important to anticipate and 
discuss as early as possible. Additionally, synthetic biology not only holds the prospect of 
bold new, and hopefully beneficial, applications. With its aim to design, engineer and build 
novel biological systems that do not occur in nature as well as to re-engineer systems that 
already exist, it raises fundamental ethical questions about the moral status of life, the 
conceptualization of risks and benefits as well as possible implications for future people. 
Finally, questions also arise about how we should approach these ethical issues and the 
moral grounding which ought to guide policy and regulatory issues in this area. This special 
issue covers aspects of all these topics through addressing questions such as: ‘What are 
appropriate methodological paradigms for ethical debates over synthetic biology for human 
health?’, ‘What questions does synthetic biology for human health pose with regards to 
justice?’, and ‘When should we consider the risks that may arise in the development of 
synthetic biology applications for human health as morally justifiable to take?’ 
An important background to this issue is an international three-year project funded by the 
European Commission, 7th Framework. The Synthetic Biology for Human Health: Ethical and 
Legal Issues (SYBHEL) project ran from 2009 to 2012 (sybhel.org). It brought together five 
European institutions expert in varying components of the debate over Synthetic Biology. 
The project objectives included: to carry out quality ethical research and evaluation of 
Synthetic Biology as it will impact human health and wellbeing; to agree recommendations 
for regulation and commercialization of synthetic biology for human health; and to 
determine a strategy for policy deliberation in this area. Specific issues investigated, in 
addition to the project objectives, were: synthetic biology and the philosophical and ethical 
conceptions and definitions of life; critiquing various methodological approaches to applied 
ethics reasoning within synthetic biology as applied to human health; and analysis of 
substantive concepts in synthetic biology for health, such as ‘suffering’ and ‘well-being’. 
Each objective and theme was also investigated with reference to several cross-cutting 
themes, including the definition of synthetic biology, the latest scientific advances in the 
field, safety issues and justice. 
We are delighted that this special issue showcases articles that address the majority of the 
objectives, issues and themes of the SYBHEL project, with individual contributions 
addressing the ethical and policy issues of synthetic biology from different angles. 
Joachim Boldt explores the ethical implications of the view that synthetic biology may prove 
advantageous for biodiversity, as synthesizing novel forms of life increases the numbers of 
3 |  P a g e
 
species. He concludes that a general moral obligation to create novel species to increase 
biodiversity is not warranted. 
Sune Holm examines the concepts of health and disease in relation to the idea of 
engineered organisms. Holm argues that reflection on the possibility of artefactual 
organisms challenges naturalistic and functional theories of health and disease as proposed 
by Wakefield and Boorse. These theories rely on interpretations of disease as dysfunction in 
an evolutionary context and are not able to accommodate the possibility of disease in 
artefactual organisms. Holm raises the question of to what extent health and disease should 
be considered as states whose factual or value-neutral component is grounded in evolution. 
David Hunter explores whether there are objections against synthetic biology from the 
perspective of social justice. New technologies, including synthetic biology, may be 
objectionable because their benefits may give an unfair advantage to some and impose 
unfair levels of risk on others. In his article, Hunter applies three types of justice-based 
objections: those based on procedural justice, on outcome justice and on patterned justice. 
He argues that from the perspective of justice, there may be some issues of regulation of 
synthetic biology, but that there is no case for banning this technology. 
Bernard Baertschi deals with a central argument in the debate, the argument that 
redesigning and manipulating human life is a manifestation of hubris. Baertschi argues that, 
when adopting a scientific world view, the charge of hubris does not apply to synthetic 
biology: it is neither impossible nor immoral for human beings to create life. 
Patrick Heavey examines how components of mainstream deontological perspectives may 
be used to assess the ethics of synthetic biology, drawing on much of the existing literature 
and debate in the process. Comparing deontological analysis with the consequentialist 
approach currently dominating the bioethics literature in synthetic biology, he posits that 
synthetic biology is ethical from a deontological point of view. He concludes by suggesting a 
way forward for bioethics debates in synthetic biology; one which combines analysis from 
differing methodological foundations. 
Kevin Smith analyses the utilities and disutilities of synthetic biology. After considering (and 
rejecting) whether synthetic biology is wrong per se, Smith discusses several competing 
approaches to utilitarian analysis: a laissez faire approach, a dual use approach, a knowledge 
approach and a precautionary approach. He argues that ethics in synthetic biology should 
be assessed on a case by case basis using a laissez faire approach. 
Synthetic Biology is a promising technology that raises challenging ethical and philosophical 
questions. This Special Issue brings together a range of theoretical perspectives to analyse 
the implications of synthetic biology as applied to human health: what are the implications 
for social justice, for our thinking about health and disease, our views on creation of life, the 
impact on biodiversity and risks for society? The issue brings together utilitarian and 
deontological approaches, perspectives of justice, philosophy of biology and philosophical 
anthropology. Such a multitude of perspectives may help to assess the acceptability, the 
risks and the merits of this new technology, which may help future policy-making. The 
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editors hope that this issue will help to inform and further develop the debate whether 
‘synbio’ can be a blessing for human health or a source of serious concerns. 
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